Prospects for limiting access to prenatal genetic information about Down syndrome in light of the expansion of prenatal genomics.

IF 1.4 Q2 ETHICS
Chris Kaposy
{"title":"Prospects for limiting access to prenatal genetic information about Down syndrome in light of the expansion of prenatal genomics.","authors":"Chris Kaposy","doi":"10.1080/20502877.2022.2130720","DOIUrl":null,"url":null,"abstract":"<p><p>Down syndrome (Trisomy 21) is a mild to moderate intellectual disability. Historically, this condition has been a primary target for prenatal testing. However, Down syndrome has not been targeted for prenatal testing because it is an especially severe illness. The condition was just one that could be easily identified prenatally using the techniques first available decades ago. We are moving into an era in which we can prenatally test for a vast range of human traits. I argue that when we can test for anything, there is no longer any reason to continue targeting Down syndrome. I present an argument based on the value of nondiscrimination. It is justified to set limits on access to prenatal information if the information is going to be used for discriminatory purposes. I use the examples of (1) prenatal testing for misogynistic fetal sex selection, and (2) homophobia-motivated prenatal testing for potential homosexuality, as compelling analogies.</p>","PeriodicalId":43760,"journal":{"name":"New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body","volume":"29 3","pages":"226-246"},"PeriodicalIF":1.4000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20502877.2022.2130720","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ETHICS","Score":null,"Total":0}
引用次数: 0

Abstract

Down syndrome (Trisomy 21) is a mild to moderate intellectual disability. Historically, this condition has been a primary target for prenatal testing. However, Down syndrome has not been targeted for prenatal testing because it is an especially severe illness. The condition was just one that could be easily identified prenatally using the techniques first available decades ago. We are moving into an era in which we can prenatally test for a vast range of human traits. I argue that when we can test for anything, there is no longer any reason to continue targeting Down syndrome. I present an argument based on the value of nondiscrimination. It is justified to set limits on access to prenatal information if the information is going to be used for discriminatory purposes. I use the examples of (1) prenatal testing for misogynistic fetal sex selection, and (2) homophobia-motivated prenatal testing for potential homosexuality, as compelling analogies.

鉴于产前基因组学的扩展,限制获取唐氏综合症产前遗传信息的前景。
唐氏综合症(21三体)是一种轻度到中度的智力残疾。从历史上看,这种情况一直是产前检测的主要目标。然而,唐氏综合症并不是产前检测的目标,因为它是一种特别严重的疾病。这种情况只是一种可以通过几十年前首次使用的技术轻松识别的情况。我们正在进入一个可以在产前测试大量人类特征的时代。我认为,当我们可以检测任何东西时,就没有理由继续以唐氏综合症为目标。我提出了一个基于不歧视价值的论点。如果产前信息将被用于歧视性目的,那么对获取产前信息设置限制是合理的。我用(1)厌恶女性的胎儿性别选择的产前检测和(2)同性恋恐惧症驱动的潜在同性恋的产前检测作为令人信服的类比。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.30
自引率
16.70%
发文量
45
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信